Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
7 evidence topics · 6 sources
Duravyu (vorolanib intravitreal insert)
Wet age-related macular degeneration
- Manufacturer
- EyePoint
- Regulatory submission
- NDA planned for the first half of 2027
- Launch
- Not announced
- Last updated